Global Hoarding Disorder Market – Industry Trends and Forecast to 2030

Hoarding Disorder Market Analysis and Size

A hoarding condition occurs when a person accumulates an excessive number of objects and keeps them in an unorganised manner, resulting in unmanageable clutter. It's possible that the items have little or no monetary worth. Hoarding disorders are difficult to cure because many hoarders are unaware that they have a problem or are unaware of how it affects their lives or the lives of others. This neurological disorder is characterised by living in unusable spaces due to clutter, inability to get rid of possessions, anxiety about needing items in the future, extreme stress about throwing out items, distrust of others touching possessions, uncertainty about where to put things, withdrawing from friends and family, among others.

Data Bridge Market Research analyses that the Hoarding Disorder market was valued at USD 978.98 million in 2022 and is expected to reach the value of USD 1,381.58 million by the year 2030, at a CAGR of 4.40% during the forecast period. This indicates that the market value. “Cognitive-Behavioral Therapy (CBT)” dominates the treatment segment of the hoarding disorder market owing to the increasing prevalence of cardiac arrhythmias. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Hoarding Disorder Market Scope and Segmentation

Market Definition

Hoarding disorder market refers to the market for products, therapies, and services aimed at addressing the symptoms and challenges associated with hoarding disorder. It includes medications, counseling, professional organizing services, and other interventions designed to assist individuals in managing and reducing hoarding behaviors.

Global Hoarding Disorder Market Dynamics

Drivers

• Increased Awareness and Understanding of Hoarding Disorder

Growing awareness among the general public, healthcare professionals, and mental health organizations about hoarding disorder contributes to increased recognition and diagnosis of the condition, driving the demand for appropriate interventions.

• Rising Prevalence of the Disorder

Hoarding disorder is being increasingly recognized as a distinct mental health condition, with prevalence rates estimated to be higher than previously thought. The rising prevalence fuels the demand for interventions and treatment options.

• Advancements in Therapeutic Approaches

Ongoing research and advancements in therapeutic approaches, such as cognitive-behavioral therapy (CBT), motivational interviewing, and harm reduction strategies, offer promising options for the treatment of hoarding disorder, stimulating market growth.  

Opportunities

The government initiatives, schemes, or funding that support and promotes the innovation and development of the Hoarding Disorder market provide growth opportunities for the market players in the forecast period of 2023 to 2030. Additionally, the Development of Innovative and Personalized Treatment approaches, collaborations between healthcare professionals and mental health organizations, penetration rate, market expansion in developing countries, and increasing per capita expenditure on healthcare will further expand the market's growth rate in the future. 

Restraints

Limited Access to Specialized Care

Access to specialized care for hoarding disorder, including mental health professionals with expertise in hoarding behavior, may be limited in certain regions or healthcare systems. This can hinder timely and appropriate treatment.

Challenges

Lack of Standardized Diagnostic Criteria and Treatment Guidelines

The absence of universally accepted diagnostic criteria and treatment guidelines for hoarding disorder can lead to variations in diagnosis and treatment approaches, posing challenges in ensuring consistent and effective care. Also, co-occurring mental health conditions, challenges in engaging and sustaining individuals in treatment, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.

This hoarding disorder market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Hoarding Disorder market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In June 2023, The Recovery Village estimated that hoarding affects 1 in every 50 people, but it may impact as many as 1 in every 20. According to the National Alliance on Mental Illness (NAMI), Massachusetts, up to 5 percent of the world’s population displays symptoms of clinically-diagnosable hoarding.

Global Hoarding Disorder Market Scope

The hoarding disorder market is segmented on the basis of treatment, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Cognitive-Behavioral Therapy (CBT)
• Antidepressants
• Others

Symptoms

• Living in unusable spaces due to clutter
• Inability to get rid of possessions
• Anxiety about needing items in the future
• Extreme stress about throwing out items
• Distrust of others touching possessions
• Uncertainty about where to put things
• Withdrawing from friends and family
• Others

Dosage

• Tablet
• Injection
• Others

Route of Administration

• Oral
• Intravenous
• Others

End-Users

• Clinic
• Hospital
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Hoarding Disorder Market Regional Analysis/Insights

The hoarding disorder market is analysed, and market size insights and trends are provided by country, treatment, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the hoarding disorder market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the hoarding disorder market due to the presence of major key players, high healthcare expenditure and well-developed healthcare infrastructure in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The hoarding disorder market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the hoarding disorder market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the Hoarding Disorder market. The data is available for the historic period 2010-2020.

Competitive Landscape and Global Hoarding Disorder Market Share Analysis

The hoarding disorder market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the hoarding disorder market.

Some of the major players operating in the hoarding disorder market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France),
• Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Novartis AG (Switzerland)
• AstraZeneca (UK)
• Johnson & Johnson (US)
• Bayer AG (Germany)
• Sun Pharmaceutical Industries Ltd. (India)
• Eli Lilly and Company (US)
• Edenbridge Pharmaceuticals, LLC (US)
• ParaPRO LLC (US)
• Encube Ethicals (India)
• GALDERMA (Switzerland)
• Alliance Pharmaceuticals (UK)
• Foamix Pharmaceuticals Ltd (US)
• Arbor Pharmaceuticals (US)
• Dr. Reddy's Laboratories Ltd. (India)
• Perrigo Company plc (Ireland)

SKU-67030